National Institute for Psychiatry and Neurology, Budapest, Hungary.
Int J Psychiatry Clin Pract. 2005;9(2):145-8. doi: 10.1080/13651500510028977.
Data from the United States and from several European countries show that patients with major mood disorders, schizophrenia and social phobia smoke at significantly higher rates than the general population. However, there are no published results on this field from Central Europe, including Hungary. In the present study, the rate of current and lifetime smoking of the consecutively screened outpatients with DSM-IV unipolar major depression (n=92), bipolar disorder (n=60), schizophrenia (n=80), schizoaffective disorder (n=42) and panic disorder without major depression (n=60) were assessed and the data were compared to the controls (n=5503), representative for the general population of Hungary. The results showed that, compared to controls, the rates of current and lifetime smoking were significantly higher among patients with unipolar major depression, bipolar disorder, schizophrenia and schizoaffective disorder, but not among patients with panic disorder without major depression. The findings support previous findings from other countries on the strong relationship between cigarette smoking and major mood and schizophrenic spectrum disorders.
来自美国和多个欧洲国家的数据显示，患有重度情绪障碍、精神分裂症和社交恐惧症的患者吸烟率明显高于普通人群。然而，包括匈牙利在内的中欧地区尚未有关于这一领域的发表结果。在本研究中，我们评估了连续筛选出的符合 DSM-IV 单相重度抑郁症（n=92）、双相情感障碍（n=60）、精神分裂症（n=80）、分裂情感性障碍（n=42）和无重度抑郁症的惊恐障碍（n=60）患者的当前和终生吸烟率，并将这些数据与代表匈牙利普通人群的对照组（n=5503）进行了比较。结果表明，与对照组相比，单相重度抑郁症、双相情感障碍、精神分裂症和分裂情感性障碍患者的当前和终生吸烟率显著更高，但无重度抑郁症的惊恐障碍患者的吸烟率并无显著差异。这些发现支持了其他国家关于吸烟与重度情绪和精神分裂症谱系障碍之间强相关性的先前发现。
